Could hyaluronic acid be the next essential tool in veterinary dentistry? Hyaluronic acid (HA) is a naturally occurring biomaterial that stabilizes and hydrates the extracellular matrix. Exogenous HA has been used in a wide variety of human and animal settings, including in joints, ophthalmology, wound care, and dermatology. While available for years in human dentistry, HA has recently emerged as an important new tool for improving clinical outcomes in both routine and specialty dentistry....

Join Dr. Wendy S. Myers on November 3, 2026, at 7:00 p.m. (EST) for this live presentation, where she will share her best practices for working with clients to improve treatment adherence in cats with diabetes. Veterinarians and their teams play a pivotal role in helping diabetic cats thrive. This webcast will show you how to do it with clarity, confidence, and compassion. Learn communication techniques that strengthen client trust, boost compliance, and make once-daily dosing easier for...

Join us on Saturday, October 24, 2026 | 11:45 a.m.-4:15 p.m. (EDT) for RVT PWR 2026, CommuniVET’s annual virtual continuing education event dedicated to supporting and empowering RVTs across Canada. This year’s program focuses on feline diabetes, with four practical sessions designed to strengthen your confidence in supporting diabetic cats and the people who care for them. Eligible for up to 4 continuing education credits! THIS YEAR'S LINEUP: 11:50 a.m.-12:45 p.m. ET | Jolene Watson, RVT...

Join Dr. Susan Little on October 20, 2026, at 7 p.m. (EDT) for this presentation, as she reviews the new SGLT2 inhibitor class of drugs for the treatment of diabetes in cats. In this presentation, Dr. Little will review the new SGLT2 inhibitor class of drugs for the treatment of diabetes in cats, including the mechanism of action, clinical efficacy, and potential adverse events. How to identify the best candidates for treatment will be discussed and practical recommendations for monitoring...

Join Dr. Rebecca De Arburn Parent and Dr. Carolyne Hours, on October 13, 2026 at 7 p.m. (EDT) for this presentation as they offer a practical, clinically focused conversation on feline arthritis. Together, they will review the often subtle signs of the condition and explore why it remains frequently underdiagnosed. The conversation will focus on how to help pet owners recognize arthritis pain, including key questions, real-life examples, and putting changes often “attributed to aging” into...

Join Dr. Ashley Spencer on October 15, 2026, at 7 p.m. (EDT) for this presentation as she discusses the challenges linked to the recognition of vector-borne diseases in dogs. Vector-borne diseases in dogs can be challenging to recognize, with vague or overlapping clinical signs and imperfect diagnostic tools. This case-based session will outline when to consider these infections, how to select and interpret diagnostic tests, and the strengths and limitations of options such as serology, PCR,...

Join Dr. Anthony Yu for this presentation on the strategic use of dermatopicals containing Ophytrium in veterinary dermatology. Topical therapies are key to managing skin conditions including allergies, seborrheic dermatitis, and secondary bacterial and yeast infections. This webinar will focus on the beneficial properties of Ophytrium in the DOUXO® S3 line of topical products and new strategies on when to use which products to help enhance the epidermal barrier and promote antimicrobial...

Join Dr. Susan Little for this presentation on the newest SGLT2 inhibitor option for diabetic cats in Canada. A new era in feline medicine began in 2024 when the first SGLT2 inhibitor for diabetic cats in Canada was introduced (velagliflozin). Now a second SGLT2 inhibitor (bexagliflozin) is finally available. This webinar will build on the experiences of using this drug class in cats to highlight what we have learned and to introduce bexagliflozin, a new option that will improve quality of...